STERIS plc
General ticker "STE" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $23.2B (TTM average)
STERIS plc does not follow the US Stock Market performance with the rate: -17.0%.
Estimated limits based on current volatility of 1.3%: low 219.23$, high 224.91$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-09-04, amount 0.69$ (Y1.24%)
- Total employees count: 17937 (+0.8%) as of 2026
- US accounted for 73.4% of revenue in the fiscal year ended 2025-03-31
- Top business risk factors: Economic downturns and volatility, Liquidity and credit risks, Product liability claims, Regulatory and compliance, Supply chain disruptions
- Price in estimated range
- Earnings for 15 months up through Q1 (+1 year) are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [188.54$, 258.79$]
- 2026-03-31 to 2027-03-31 estimated range: [201.95$, 274.98$]
Financial Metrics affecting the STE estimates:
- Negative: with PPE of 24.2 at the end of fiscal year the price was high
- Positive: 15.80 < Operating profit margin, % of 15.87
- Positive: 4.90 < Operating cash flow per share per price, % of 5.21
- Positive: 5.14 < Return on assets ratio (scaled to [-100,100]) of 5.68
- Positive: -51.61 < Industry operating profit margin (median), % of -38.22
- Negative: 0.33 < Interest expense per share per price, % of 0.39
- Positive: -0.14 < Investing cash flow per share per price, % of 1.76
Short-term STE quotes
Long-term STE plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | $4,536.27MM | $5,138.70MM | $5,459.52MM |
| Operating Expenses | $3,745.16MM | $4,302.58MM | $4,592.87MM |
| Operating Income | $791.10MM | $836.12MM | $866.64MM |
| Non-Operating Income | $-110.83MM | $-133.31MM | $-70.43MM |
| Interest Expense | $107.96MM | $144.35MM | $86.26MM |
| R&D Expense | $98.48MM | $103.68MM | $107.65MM |
| Income(Loss) | $680.27MM | $702.81MM | $796.21MM |
| Taxes | $124.07MM | $149.53MM | $184.65MM |
| Other Income(Loss) | $-450.38MM | $-173.20MM | $4.52MM |
| Net Income(Loss)* | $107.03MM | $378.24MM | $614.64MM |
| Stockholders Equity | $6,077.20MM | $6,302.16MM | $6,603.40MM |
| Inventory | $604.41MM | $674.53MM | $581.33MM |
| Assets | $10,821.84MM | $11,063.70MM | $10,146.81MM |
| Operating Cash Flow | $756.95MM | $973.27MM | $1,148.09MM |
| Capital expenditure | $361.97MM | $360.33MM | $370.09MM |
| Investing Cash Flow | $-383.33MM | $-887.36MM | $388.77MM |
| Financing Cash Flow | $-498.72MM | $-85.19MM | $-1,572.36MM |
| Earnings Per Share** | $1.07 | $3.83 | $6.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.